The association of anti-phospholipid antibodies with parity in placental malaria.
Identifieur interne : 000883 ( PubMed/Curation ); précédent : 000882; suivant : 000884The association of anti-phospholipid antibodies with parity in placental malaria.
Auteurs : S. Owens [Gambie] ; L W Chamley ; J. Ordi ; B J Brabin ; P M JohnsonSource :
- Clinical and experimental immunology [ 0009-9104 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte, Anticoagulants (immunologie), Anticorps anticardiolipines (immunologie), Anticorps antiphospholipides (immunologie), Apolipoprotéines (immunologie), Cardiolipides (immunologie), Complications de la grossesse et maladies infectieuses (immunologie), Femelle, Glycoprotéines (immunologie), Grossesse, Humains, Immunoglobuline G (analyse), Maladies du placenta (immunologie), Paludisme (immunologie), Parité (immunologie), Phosphatidylsérine (immunologie), Test ELISA (), bêta 2-Glycoprotéine I, Études transversales.
- MESH :
- analyse : Immunoglobuline G.
- immunologie : Anticoagulants, Anticorps anticardiolipines, Anticorps antiphospholipides, Apolipoprotéines, Cardiolipides, Complications de la grossesse et maladies infectieuses, Glycoprotéines, Maladies du placenta, Paludisme, Parité, Phosphatidylsérine.
- Adulte, Femelle, Grossesse, Humains, Test ELISA, bêta 2-Glycoprotéine I, Études transversales.
English descriptors
- KwdEn :
- Adult, Antibodies, Anticardiolipin (immunology), Antibodies, Antiphospholipid (immunology), Anticoagulants (immunology), Apolipoproteins (immunology), Cardiolipins (immunology), Cross-Sectional Studies, Enzyme-Linked Immunosorbent Assay (methods), Female, Glycoproteins (immunology), Humans, Immunoglobulin G (analysis), Malaria (immunology), Parity (immunology), Phosphatidylserines (immunology), Placenta Diseases (immunology), Pregnancy, Pregnancy Complications, Infectious (immunology), beta 2-Glycoprotein I.
- MESH :
- chemical , analysis : Immunoglobulin G.
- chemical , immunology : Antibodies, Anticardiolipin, Antibodies, Antiphospholipid, Anticoagulants, Apolipoproteins, Cardiolipins, Glycoproteins, Phosphatidylserines.
- immunology : Malaria, Parity, Placenta Diseases, Pregnancy Complications, Infectious.
- methods : Enzyme-Linked Immunosorbent Assay.
- Adult, Cross-Sectional Studies, Female, Humans, Pregnancy, beta 2-Glycoprotein I.
Abstract
Anti-phospholipid antibodies (aPL) are autoantibodies associated with both infections and the pathogenesis of certain pregnancy complications. In the latter, but not the former, aPL are dependent on a co-factor, beta(2) glycoprotein I (beta2GPI), which can also be used as an antigen for detection of such aPL in pregnancy. A cross-sectional study was carried out on serum samples from Kumasi, Ghana, to determine the occurrence and beta2GPI-dependence of aPL in placental malaria. Anti-cardiolipin, anti-phosphatidylserine and anti-beta2GPI enzyme-linked immunosorbent assays (ELISAs) were performed on sera from 103 HIV-non-infected gravid women. Placental malaria, both active and past infection, was diagnosed in 33/103 (32%) based on placental histology. In multiparae, beta2GPI-independent IgM antibodies to cardiolipin (P = 0.018) and phosphatidylserine (P = 0.009) were observed, which were most pronounced in past placental malaria infection. In primiparae, no association emerged between aPL and placental malaria. Trends for improved clinical parameters were identified in infected women with levels of anti-cardiolipin beyond the 99th multiple of the median for a healthy, non-malarious population. This study in placental malaria reports parity associations of beta2GPI-independent aPL profiles, and does not support a role for beta2GPI-dependent aPL. It is of significance in the context of the known parity differences in pregnancy malaria immunity.
DOI: 10.1111/j.1365-2249.2005.02936.x
PubMed: 16297164
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000884
Links to Exploration step
pubmed:16297164Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The association of anti-phospholipid antibodies with parity in placental malaria.</title><author><name sortKey="Owens, S" sort="Owens, S" uniqKey="Owens S" first="S" last="Owens">S. Owens</name><affiliation wicri:level="1"><nlm:affiliation>MRC Laboratories, Atlantic Road, Fajara, The Gambia.</nlm:affiliation><country xml:lang="fr">Gambie</country><wicri:regionArea>MRC Laboratories, Atlantic Road, Fajara</wicri:regionArea></affiliation></author><author><name sortKey="Chamley, L W" sort="Chamley, L W" uniqKey="Chamley L" first="L W" last="Chamley">L W Chamley</name></author><author><name sortKey="Ordi, J" sort="Ordi, J" uniqKey="Ordi J" first="J" last="Ordi">J. Ordi</name></author><author><name sortKey="Brabin, B J" sort="Brabin, B J" uniqKey="Brabin B" first="B J" last="Brabin">B J Brabin</name></author><author><name sortKey="Johnson, P M" sort="Johnson, P M" uniqKey="Johnson P" first="P M" last="Johnson">P M Johnson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16297164</idno><idno type="pmid">16297164</idno><idno type="doi">10.1111/j.1365-2249.2005.02936.x</idno><idno type="wicri:Area/PubMed/Corpus">000884</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000884</idno><idno type="wicri:Area/PubMed/Curation">000883</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000883</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The association of anti-phospholipid antibodies with parity in placental malaria.</title><author><name sortKey="Owens, S" sort="Owens, S" uniqKey="Owens S" first="S" last="Owens">S. Owens</name><affiliation wicri:level="1"><nlm:affiliation>MRC Laboratories, Atlantic Road, Fajara, The Gambia.</nlm:affiliation><country xml:lang="fr">Gambie</country><wicri:regionArea>MRC Laboratories, Atlantic Road, Fajara</wicri:regionArea></affiliation></author><author><name sortKey="Chamley, L W" sort="Chamley, L W" uniqKey="Chamley L" first="L W" last="Chamley">L W Chamley</name></author><author><name sortKey="Ordi, J" sort="Ordi, J" uniqKey="Ordi J" first="J" last="Ordi">J. Ordi</name></author><author><name sortKey="Brabin, B J" sort="Brabin, B J" uniqKey="Brabin B" first="B J" last="Brabin">B J Brabin</name></author><author><name sortKey="Johnson, P M" sort="Johnson, P M" uniqKey="Johnson P" first="P M" last="Johnson">P M Johnson</name></author></analytic><series><title level="j">Clinical and experimental immunology</title><idno type="ISSN">0009-9104</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antibodies, Anticardiolipin (immunology)</term><term>Antibodies, Antiphospholipid (immunology)</term><term>Anticoagulants (immunology)</term><term>Apolipoproteins (immunology)</term><term>Cardiolipins (immunology)</term><term>Cross-Sectional Studies</term><term>Enzyme-Linked Immunosorbent Assay (methods)</term><term>Female</term><term>Glycoproteins (immunology)</term><term>Humans</term><term>Immunoglobulin G (analysis)</term><term>Malaria (immunology)</term><term>Parity (immunology)</term><term>Phosphatidylserines (immunology)</term><term>Placenta Diseases (immunology)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (immunology)</term><term>beta 2-Glycoprotein I</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Anticoagulants (immunologie)</term><term>Anticorps anticardiolipines (immunologie)</term><term>Anticorps antiphospholipides (immunologie)</term><term>Apolipoprotéines (immunologie)</term><term>Cardiolipides (immunologie)</term><term>Complications de la grossesse et maladies infectieuses (immunologie)</term><term>Femelle</term><term>Glycoprotéines (immunologie)</term><term>Grossesse</term><term>Humains</term><term>Immunoglobuline G (analyse)</term><term>Maladies du placenta (immunologie)</term><term>Paludisme (immunologie)</term><term>Parité (immunologie)</term><term>Phosphatidylsérine (immunologie)</term><term>Test ELISA ()</term><term>bêta 2-Glycoprotéine I</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Anticardiolipin</term><term>Antibodies, Antiphospholipid</term><term>Anticoagulants</term><term>Apolipoproteins</term><term>Cardiolipins</term><term>Glycoproteins</term><term>Phosphatidylserines</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticoagulants</term><term>Anticorps anticardiolipines</term><term>Anticorps antiphospholipides</term><term>Apolipoprotéines</term><term>Cardiolipides</term><term>Complications de la grossesse et maladies infectieuses</term><term>Glycoprotéines</term><term>Maladies du placenta</term><term>Paludisme</term><term>Parité</term><term>Phosphatidylsérine</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Malaria</term><term>Parity</term><term>Placenta Diseases</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Pregnancy</term><term>beta 2-Glycoprotein I</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Test ELISA</term><term>bêta 2-Glycoprotéine I</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Anti-phospholipid antibodies (aPL) are autoantibodies associated with both infections and the pathogenesis of certain pregnancy complications. In the latter, but not the former, aPL are dependent on a co-factor, beta(2) glycoprotein I (beta2GPI), which can also be used as an antigen for detection of such aPL in pregnancy. A cross-sectional study was carried out on serum samples from Kumasi, Ghana, to determine the occurrence and beta2GPI-dependence of aPL in placental malaria. Anti-cardiolipin, anti-phosphatidylserine and anti-beta2GPI enzyme-linked immunosorbent assays (ELISAs) were performed on sera from 103 HIV-non-infected gravid women. Placental malaria, both active and past infection, was diagnosed in 33/103 (32%) based on placental histology. In multiparae, beta2GPI-independent IgM antibodies to cardiolipin (P = 0.018) and phosphatidylserine (P = 0.009) were observed, which were most pronounced in past placental malaria infection. In primiparae, no association emerged between aPL and placental malaria. Trends for improved clinical parameters were identified in infected women with levels of anti-cardiolipin beyond the 99th multiple of the median for a healthy, non-malarious population. This study in placental malaria reports parity associations of beta2GPI-independent aPL profiles, and does not support a role for beta2GPI-dependent aPL. It is of significance in the context of the known parity differences in pregnancy malaria immunity.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16297164</PMID><DateCreated><Year>2005</Year><Month>11</Month><Day>21</Day></DateCreated><DateCompleted><Year>2006</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2014</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0009-9104</ISSN><JournalIssue CitedMedium="Print"><Volume>142</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical and experimental immunology</Title><ISOAbbreviation>Clin. Exp. Immunol.</ISOAbbreviation></Journal><ArticleTitle>The association of anti-phospholipid antibodies with parity in placental malaria.</ArticleTitle><Pagination><MedlinePgn>512-8</MedlinePgn></Pagination><Abstract><AbstractText>Anti-phospholipid antibodies (aPL) are autoantibodies associated with both infections and the pathogenesis of certain pregnancy complications. In the latter, but not the former, aPL are dependent on a co-factor, beta(2) glycoprotein I (beta2GPI), which can also be used as an antigen for detection of such aPL in pregnancy. A cross-sectional study was carried out on serum samples from Kumasi, Ghana, to determine the occurrence and beta2GPI-dependence of aPL in placental malaria. Anti-cardiolipin, anti-phosphatidylserine and anti-beta2GPI enzyme-linked immunosorbent assays (ELISAs) were performed on sera from 103 HIV-non-infected gravid women. Placental malaria, both active and past infection, was diagnosed in 33/103 (32%) based on placental histology. In multiparae, beta2GPI-independent IgM antibodies to cardiolipin (P = 0.018) and phosphatidylserine (P = 0.009) were observed, which were most pronounced in past placental malaria infection. In primiparae, no association emerged between aPL and placental malaria. Trends for improved clinical parameters were identified in infected women with levels of anti-cardiolipin beyond the 99th multiple of the median for a healthy, non-malarious population. This study in placental malaria reports parity associations of beta2GPI-independent aPL profiles, and does not support a role for beta2GPI-dependent aPL. It is of significance in the context of the known parity differences in pregnancy malaria immunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Owens</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRC Laboratories, Atlantic Road, Fajara, The Gambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamley</LastName><ForeName>L W</ForeName><Initials>LW</Initials></Author><Author ValidYN="Y"><LastName>Ordi</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Brabin</LastName><ForeName>B J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>P M</ForeName><Initials>PM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017153">Antibodies, Anticardiolipin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017152">Antibodies, Antiphospholipid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001053">Apolipoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002308">Cardiolipins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010718">Phosphatidylserines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053482">beta 2-Glycoprotein I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Immunology. 1993 Aug;79(4):653-7</RefSource><PMID Version="1">8406592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunology. 1993 May;79(1):138-45</RefSource><PMID Version="1">8509134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol. 1997 Oct;27(10):1251-63</RefSource><PMID Version="1">9394195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1998 Mar 1;160(5):2523-30</RefSource><PMID Version="1">9498798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):50-3</RefSource><PMID Version="1">9692151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 1998 Aug;22(8):1006-11</RefSource><PMID Version="1">9706981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1998 Sep 26;352(9133):1037-8</RefSource><PMID Version="1">9759755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 1998 Nov;70(5):938-44</RefSource><PMID Version="1">9806580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Reprod Immunol. 1999 Feb;41(2):133-52</RefSource><PMID Version="1">10102085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Paediatr. 2004 Dec;24(4):311-21</RefSource><PMID Version="1">15720888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 2000 Jan;31(1):85-93</RefSource><PMID Version="1">10665918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2000 May;181(5):1740-5</RefSource><PMID Version="1">10823776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2000 Oct 2;76(3):205-21</RefSource><PMID Version="1">10974161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2002 Jan;127(1):158-64</RefSource><PMID Version="1">11882047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Dis Child Fetal Neonatal Ed. 2002 May;86(3):F182-7</RefSource><PMID Version="1">11978749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Reprod Immunol. 2002 Oct-Nov;57(1-2):185-202</RefSource><PMID Version="1">12385842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2003 Jan;71(1):267-70</RefSource><PMID Version="1">12496175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Placenta. 2004 May;25(5):359-78</RefSource><PMID Version="1">15081631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2004 May;90(3):277-84</RefSource><PMID Version="1">15099815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Trop Paediatr. 2004 Jun;24(2):161-9</RefSource><PMID Version="1">15186545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Immunol. 2004 Aug;112(2):129-35</RefSource><PMID Version="1">15240155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Immunol. 2004 Aug;112(2):161-8</RefSource><PMID Version="1">15240159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Immunol. 2004 Aug;112(2):169-74</RefSource><PMID Version="1">15240160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2004 Sep;72(9):5267-73</RefSource><PMID Version="1">15322022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1983;61(6):1005-16</RefSource><PMID Version="1">6370484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1990 Nov 17;336(8725):1201-4</RefSource><PMID Version="1">1978068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lupus. 1992 Feb;1(2):75-81</RefSource><PMID Version="1">1301967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Placenta. 1997 Jul-Aug;18(5-6):403-10</RefSource><PMID Version="1">9250702</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017153" MajorTopicYN="N">Antibodies, Anticardiolipin</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017152" MajorTopicYN="N">Antibodies, Antiphospholipid</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001053" MajorTopicYN="N">Apolipoproteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002308" MajorTopicYN="N">Cardiolipins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010718" MajorTopicYN="N">Phosphatidylserines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010922" MajorTopicYN="N">Placenta Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053482" MajorTopicYN="N">beta 2-Glycoprotein I</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC1809541</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>11</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>11</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16297164</ArticleId><ArticleId IdType="pii">CEI2936</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2249.2005.02936.x</ArticleId><ArticleId IdType="pmc">PMC1809541</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:16297164
|texte= The association of anti-phospholipid antibodies with parity in placental malaria.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16297164" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |